GlassScriptPhysician profile
Jack A Harvey
NPI 1033475678
$4,070.09
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $886 · 2021: $49.28 · 2022: $1,015 · 2023: $112 · 2024: $231 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical, INC. | $1,067.00 | 2019 | |
| Treace Medical Concepts, INC. | $835.04 | 2022 | |
| In2bones USA, LLC | $700.00 | 2020 | |
| Medical Device Business Services, INC. | $338.86 | 2019 | |
| Smith+Nephew, INC. | $248.88 | 2019-2024 | Collagenase Santyl |
| Paragon 28, INC. | $138.18 | 2021-2024 | Mtp |
| Mimedx Group, INC. | $131.51 | 2024-2025 | |
| Averitas Pharma INC. | $94.74 | 2023 | Qutenza |
| Polynovo North America LLC | $87.73 | 2025 | Novosorb Btm |
| Nevro Corp. | $86.04 | 2022 | |
| Horizon Therapeutics Plc | $85.28 | 2019 | |
| Organogenesis INC. | $79.64 | 2020 | |
| Arthrosurface Incorporated | $77.81 | 2019-2020 | |
| Abbott Laboratories | $29.12 | 2019-2022 | |
| Amgen INC. | $19.18 | 2024 | Krystexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $16.80 | 2023 | |
| Medtronic, INC. | $15.22 | 2024 | Venaseal |
| Paratek Pharmaceuticals, INC. | $13.32 | 2020 | |
| Forte Bio-Pharma LLC | $5.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.